Sofija Jovic, PhD, MBA | Business Transformation Advisor

Dr. Jovic joined WCG in 2017 when WCG acquired ProPhase, a leading global provider of specialized tools to support measurement-related activities in clinical trials. She now serves as a member of WCG’s MedAvante-ProPhase executive team. Dr. Jovic led ProPhase as co-founder, CEO and managing board member for more than 10 years, transforming it from a start up to a market leader. ProPhase’s portfolio includes electronic clinical outcome assessments and endpoint surveillance solutions, rater training and certification, and study start-up support.

  • CNS Science Has Outpaced Tool Development; It’s Time to Catch Up

    CNS Science Has Outpaced Tool Development; It’s Time to Catch Up

    For the first time in decades, we’re developing CNS drugs with new mechanisms of action. Unfortunately, our measurement tools are stuck in the past.

    Read Post
  • loading
    Loading More...